Overview

Aloe vera (Aloe barbadensis Miller) is a perennial succulent belonging to the family Asphodelaceae, cultivated worldwide for its medicinal, cosmetic, and nutritional applications. The plant's thick, fleshy leaves contain a clear gel composed primarily of water (99%) along with over 200 biologically active compounds, including acemannan (a β-(1→4)-linked acetylated mannan polysaccharide), anthraquinones (aloin, emodin), vitamins, minerals, amino acids, and salicylic acid. The latex layer between the outer rind and inner gel contains the majority of anthraquinone compounds with laxative properties.

Topical aloe vera gel has the strongest evidence base, particularly for wound healing and burn treatment. Multiple systematic reviews have found that aloe vera accelerates healing of first- and second-degree burns and may reduce healing time compared to conventional treatments. The mechanisms involve stimulation of fibroblast proliferation, increased collagen synthesis, promotion of angiogenesis, and modulation of inflammatory mediators. Aloe vera is also commonly used for dermatitis, psoriasis, and as a general skin moisturizer, with varying levels of clinical support.

Oral aloe vera preparations have been investigated for glycemic control in type 2 diabetes, gastrointestinal conditions (including irritable bowel syndrome), and immune modulation. Some clinical trials report modest improvements in fasting blood glucose and HbA1c levels, though study quality varies. Oral consumption of whole-leaf extracts containing aloin may cause diarrhea, abdominal cramping, and electrolyte imbalances. The National Toxicology Program has classified non-decolorized whole-leaf aloe vera extract as a possible carcinogen based on rodent studies, though the relevance to typical human consumption of purified inner gel remains debated.

Mechanism of Action

Primary Bioactive Constituents

Aloe vera (Aloe barbadensis Miller) contains over 75 bioactive compounds, but its pharmacological effects are primarily attributed to acemannan (acetylated mannose polysaccharide), anthraquinones (aloin, emodin), and various phenolic compounds. These constituents act through multiple overlapping pathways (PMID: 18679344).

Immunomodulatory Pathway

Acemannan is the major immunoactive polysaccharide. It binds to mannose receptors on macrophages, stimulating phagocytosis and the release of cytokines including IL-1, IL-6, TNF-alpha, and nitric oxide. Acemannan also activates the NF-kB signaling pathway, enhancing innate immune surveillance. At the same time, it modulates adaptive immunity by promoting dendritic cell maturation and antigen presentation (PMID: 21776353).

Anti-Inflammatory Mechanisms

Aloe vera inhibits the cyclooxygenase-2 (COX-2) and lipoxygenase pathways, reducing prostaglandin E2 and leukotriene B4 synthesis. The anthraquinone emodin specifically blocks IKK/NF-kB activation, attenuating the transcription of pro-inflammatory genes. Bradykinase, an enzyme present in the gel, directly hydrolyzes bradykinin, a key pain-mediating peptide (PMID: 26151870).

Wound Healing & Proliferative Effects

Aloe vera polysaccharides stimulate fibroblast proliferation and collagen synthesis via upregulation of TGF-beta1 and VEGF expression. Glucomannan interacts with growth factor receptors on fibroblasts, promoting extracellular matrix deposition. The gel also enhances epithelial cell migration through integrin-mediated signaling, accelerating wound closure (PMID: 30287361).

Antioxidant Activity

Phenolic compounds (aloesin, aloin) and vitamins C and E in the gel scavenge reactive oxygen species and upregulate superoxide dismutase (SOD), catalase, and glutathione peroxidase activity, protecting tissues from oxidative damage during inflammation.

Reconstitution Calculator

Research

Safety Profile

Common Side Effects

• Diarrhea and abdominal cramping are the most frequently reported adverse effects with oral aloe vera latex (the yellow exudate containing anthraquinones such as aloin and emodin), occurring in a dose-dependent manner.
• Electrolyte imbalances, particularly hypokalemia, with chronic oral use of aloe latex as a laxative.
• Contact dermatitis and allergic skin reactions with topical application in sensitized individuals, though this is relatively uncommon.
• Skin irritation or burning sensation when applied to deep wounds or severe burns.
• Orange-red discoloration of urine with anthraquinone-containing preparations (harmless but potentially alarming).

Contraindications

• Intestinal obstruction, acute inflammatory bowel conditions (Crohn's disease, ulcerative colitis), or appendicitis: Aloe latex acts as a stimulant laxative and can worsen these conditions.
• Hemorrhoids or rectal bleeding: Stimulant laxative action may aggravate these conditions.
• Known allergy to Liliaceae family plants (garlic, onion, tulips) may indicate cross-reactivity.
• Children under 12 years: Oral aloe latex is contraindicated due to risk of severe diarrhea and electrolyte disturbances.
• Renal disease: Chronic use may worsen nephrotoxicity; anthraquinone metabolites are renally cleared.

Drug Interactions

• Digoxin: Aloe-induced hypokalemia can potentiate digoxin toxicity, increasing risk of fatal cardiac arrhythmias.
• Diuretics (thiazides, loop diuretics): Additive potassium loss leading to dangerous hypokalemia.
• Corticosteroids: Concurrent use amplifies potassium depletion.
• Oral medications generally: Aloe latex may reduce absorption due to decreased intestinal transit time.
• Anticoagulants: Topical aloe may enhance the effects of hydrocortisone when co-applied; oral aloe may affect warfarin absorption.
• Antidiabetic medications: Aloe gel has demonstrated hypoglycemic effects in some studies; monitor for additive blood sugar lowering.
• Sevoflurane (anesthetic): Case report of excessive intraoperative bleeding possibly linked to chronic aloe use.

Special Populations

• Pregnancy: Contraindicated orally. Aloe latex may stimulate uterine contractions and has potential abortifacient properties.
• Lactation: Anthraquinones pass into breast milk; oral aloe latex is not recommended.
• Elderly: Increased susceptibility to electrolyte imbalances and dehydration.

Monitoring

• Serum electrolytes (especially potassium and sodium) with chronic oral use.
• Renal function tests with prolonged supplementation.
• Blood glucose monitoring in diabetic patients.
• Liver function tests if using oral preparations long-term.

Pharmacokinetic Profile